Skip to content
Review Open access

Human biomarker navigator

Aug 2026 · iMeta · 2 citations · 1,029 references
Medicine

TL;DR

This review offers the initial comprehensive elucidation of the biomarker interaction networks across diverse systems, organs, and diseases, and delineates the operational framework for establishing a “biomarker navigation system”.

Abstract

Abstract Biomarkers play a pivotal role in contemporary medical research, particularly in the early diagnosis of diseases and personalized treatment. Although previous studies have systematically reviewed markers across various disease domains, an integrated framework that connects major physiological systems, encompasses multiple organs, and spans a broad spectrum of diseases is still lacking. In the context of modern health challenges, marked by the high prevalence of chronic diseases and widespread comorbidities, establishing a panoramic biomarker navigation system is imperative. This review offers the initial comprehensive elucidation of the biomarker interaction networks across diverse systems, organs, and diseases, and delineates the operational framework for establishing a “biomarker navigation system”. The core contribution of this work is a transition from ‘knowledge enumeration’ to a more integrated, systems‐level approach. This provides new perspectives in systems biology for understanding the shared pathological foundations of comorbidities. Furthermore, it provides a theoretical basis for a reorientation in medicine, from a focus on ‘treating existing diseases’ to ‘preventive interventions’ and from ‘single‐disease management’ to a comprehensive, systems‐based approach. To facilitate the exploration and application of this system–organ–disease–biomarker network, we developed the “Human Biomarker Navigator” web platform (http://www.hbiomarker.com), which allows researchers and clinicians to efficiently retrieve the functional characteristics and clinical significance of diverse biomarkers across different disease contexts.

Read PDF

Similar papers

Review Open access Aug 2026

Multi‐omics–driven precision medicine

The value of MODPM lies not in stacking additional data layers but in building a multiscale, continuously learnable framework to link biological heterogeneity to clinically interpretable and actionable decisions.

Hui-Bo Li, Zhe Zhao, Yi-Fan Zhang et al. · 0 citations
Review Open access Sep 2026

Integrative multi-omics and network biology in cardiovascular disease: a systems-level framework for translational discovery

This review provides a comprehensive, systems-level framework for translational discovery in cardiovascular disease, synthesizing advances in multi-omics technologies, network biology, artificial intelligence, and bioinformatics applied to conditions including thoracic aortic aneurysm, heart failure, valvular disease,...

V. Brecher, V. Androutsopoulou, S. Sicouri et al. · 0 citations
Review Sep 2026

Targeting Senescence-Associated Biomarkers: Emerging Strategies for Anti-Ageing Therapy.

Ageing research has undergone a paradigm shift from descriptive theories to a mechanistic understanding grounded in the interconnected biological processes. This work synthesizes the current landscape of ageing research, emphasizing the critical role of biomarkers in translating mechanistic insights into clinical appli...

Zhe Qin, Lu Zhang, Jian-Ping Song et al. · 0 citations
Review Open access Oct 2026

Modeling Strategies for Neurodegenerative Diseases: In Vitro, In Vivo and In Silico Frameworks

Neurodegenerative diseases (NDs) comprise a heterogeneous group of disorders characterized by complex etiologies, multifactorial pathogenic mechanisms, and remarkable clinical and molecular variability. Their increasing prevalence poses an important challenge to healthcare systems, society and the global economy. Despi...

Francesca Martorella, C. Cigolini, Giorgia Pupo et al. · 0 citations
Review Open access Aug 2026

Multi-Omics in Kidney Disease Research: Technological Advances, Biomarker Discovery and Clinical Translation

Recent technological advances and applications of multi-omics in kidney diseases are critically reviewed, with particular attention to biomarker discovery and clinical translation, and the challenges and future directions of multi-omics integration and its application in precision medicine are discussed.

Xue-Mei Gong, Xiao-Xi Zeng, Ping Fu · 1 citation
Review

Chapter Thirteen Chapter Thirteen

J. M. Aerts, M. V. van Breemen, Anton P. Bussink et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.